Eligibility and Rate Factors

Eligibility and rate factors refer to the criteria used by insurance companies to determine whether an individual or group is eligible for coverage and the premiums that they will be charged. These factors can include a variety of personal and health-related characteristics that may impact the likelihood of a claim being filed. Some common eligibility and rate factors used in insurance include:

• Age: Insurance companies may charge higher premiums for older individuals, as they are more likely to require medical treatment.

• Health status: Insurance companies may require individuals to undergo medical exams or answer health-related questions to determine their risk of filing a claim.

• Occupation: Certain professions may be considered more high-risk, resulting in higher premiums.

• Location: Insurance companies may charge different premiums based on the location of the individual or group, as certain areas may be more prone to specific health conditions or risks.

• Lifestyle factors: Insurance companies may take into account factors such as tobacco use, alcohol consumption, and exercise habits when determining premiums.

• Pre-existing conditions: Insurance companies may exclude coverage for certain pre-existing conditions, or charge higher premiums to cover them.

For example, an insurance company offering health insurance to a group of employees may use eligibility and rate factors such as age, health status, and occupation to determine the premiums that each individual will be charged. They may also exclude coverage for certain pre-existing conditions or require individuals to undergo medical exams to assess their risk.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.